Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,949 | 881 | 94.2% |
| Education | $604.32 | 10 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $185.47 | 13 | 1.3% |
| Gift | $11.51 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $977.96 | 64 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $927.23 | 47 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $853.01 | 53 | $0 (2023) |
| UCB, Inc. | $672.12 | 39 | $0 (2023) |
| GENZYME CORPORATION | $639.39 | 32 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $623.91 | 16 | $0 (2024) |
| ABBVIE INC. | $553.93 | 45 | $0 (2023) |
| Amgen Inc. | $422.15 | 23 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $382.81 | 34 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $371.60 | 96 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $782.09 | 20 | Alexion Pharmaceuticals, Inc. ($434.99) |
| 2023 | $1,566 | 75 | Jazz Pharmaceuticals Inc. ($116.36) |
| 2022 | $1,837 | 110 | Biohaven Pharmaceutical Holding Company Ltd. ($234.83) |
| 2021 | $1,392 | 92 | AbbVie Inc. ($255.85) |
| 2020 | $767.74 | 45 | GENZYME CORPORATION ($92.77) |
| 2019 | $2,482 | 228 | UCB, Inc. ($322.89) |
| 2018 | $2,534 | 172 | Teva Pharmaceuticals USA, Inc. ($208.27) |
| 2017 | $2,389 | 163 | Novartis Pharmaceuticals Corporation ($212.50) |
All Payment Transactions
905 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Neurology | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PAIN | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Rare Disease | ||||||
| 09/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $134.99 | General |
| Category: Rare Disease | ||||||
| 08/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 07/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 07/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 05/31/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Central Nervous System | ||||||
| 05/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Rare Disease | ||||||
| 05/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: PAIN | ||||||
| 04/25/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $75.14 | General |
| Category: Neurology | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Rare Disease | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PAIN | ||||||
| 04/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neurology | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Rare Disease | ||||||
| 03/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Neuroscience | ||||||
| 02/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PAIN | ||||||
| 02/07/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Neurology | ||||||
| 12/12/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.65 | General |
| 11/07/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 10/31/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $55.81 | General |
| Category: Neurology | ||||||
| 08/23/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: NEUROLOGY | ||||||
| 06/29/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 816 | 917 | $220,427 | $65,201 |
| 2022 | 9 | 1,665 | 2,243 | $577,603 | $185,214 |
| 2021 | 10 | 2,139 | 2,943 | $746,121 | $246,995 |
| 2020 | 9 | 2,253 | 3,233 | $784,532 | $228,500 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 280 | $72,618 | $22,417 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 370 | 418 | $73,455 | $21,401 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $40,627 | $10,448 | 25.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 27 | 45 | $9,881 | $3,350 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $7,900 | $2,583 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $6,297 | $2,133 | 33.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 11 | 11 | $6,168 | $1,506 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 18 | $3,482 | $1,363 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 498 | 738 | $191,400 | $63,948 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 677 | 948 | $166,592 | $54,634 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 284 | 284 | $113,117 | $31,870 | 28.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 81 | 139 | $30,522 | $10,783 | 35.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 21 | 21 | $20,583 | $7,028 | 34.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 36 | 37 | $20,746 | $6,079 | 29.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 29 | 29 | $18,222 | $5,365 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 36 | $12,595 | $4,429 | 35.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $3,827 | $1,079 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 964 | 1,390 | $244,225 | $80,173 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 582 | 869 | $225,375 | $78,803 | 35.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 311 | 311 | $123,871 | $37,400 | 30.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 113 | 204 | $44,794 | $15,986 | 35.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 36 | 36 | $35,285 | $12,246 | 34.7% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 48 | 48 | $30,160 | $9,239 | 30.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 46 | 46 | $25,792 | $7,871 | 30.5% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 12 | 12 | $8,636 | $2,778 | 32.2% |
About Dr. Jonathan Richman, MD
Dr. Jonathan Richman, MD is a Neurology healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750347266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Richman, MD has received a total of $13,751 in payments from pharmaceutical and medical device companies, with $782.09 received in 2024. These payments were reported across 905 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($12,949).
As a Medicare-enrolled provider, Richman has provided services to 6,873 Medicare beneficiaries, totaling 9,336 services with total Medicare billing of $725,910. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Fayetteville, NC
- Active Since 04/24/2006
- Last Updated 05/20/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750347266
Products in Payments
- NURTEC ODT (Drug) $506.23
- AUBAGIO (Drug) $495.17
- ULTOMIRIS (Biological) $460.74
- TYSABRI (Biological) $389.76
- NUPLAZID (Drug) $382.81
- KESIMPTA (Drug) $377.15
- Aimovig (Biological) $338.60
- APTIOM (Drug) $335.81
- Neupro (Drug) $318.32
- ACTHAR (Biological) $317.15
- NORTHERA (Drug) $316.42
- VUMERITY (Drug) $274.76
- UBRELVY (Drug) $268.56
- TECFIDERA (Drug) $253.82
- GILENYA (Drug) $240.55
- TROKENDI XR (Drug) $237.62
- RYTARY (Drug) $215.01
- EMGALITY (Drug) $210.37
- Rebif (Biological) $203.14
- INBRIJA (Drug) $197.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fayetteville
Dr. Kenneth Lazarus, Md,Phd, MD,PHD
Neurology — Payments: $150,967
Mr. Virendra Ranadive, Md, MD
Neurology — Payments: $81,305
Mr. Wallace Green, Pac, PAC
Neurology — Payments: $59,583
Evan Johnson, Md, MD
Neurology — Payments: $29,779
Dr. Mena Samaan, M.d, M.D
Neurology — Payments: $12,550
Dr. Muhammed Khasru, M.d, M.D
Neurology — Payments: $11,951